Eli Lilly and Company LLY GLP1 Oral Market Competition Intensifies As Early Uptake Data Benchmarks Novo Nordisks Oral Wegovy Lead EVTC Evertec posts 22 percent Q4 2025 EPS upside shares tick modestly higher in todays trading ZURA Zura Bio posts far wider Q4 2025 loss than consensus estimates sending its shares down 254 today